BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li JM, Chen H. Recurrent hypotension induced by sacubitril/valsartan in cardiomyopathy secondary to Duchenne muscular dystrophy: A case report. World J Clin Cases 2019; 7(23): 4098-4105 [PMID: 31832414 DOI: 10.12998/wjcc.v7.i23.4098]
URL: https://www.wjgnet.com/2307-8960/full/v7/i23/4098.htm
Number Citing Articles
1
Alessandra Arcudi, Marco Di Francesco, Daniele Rodolico, Domenico D'Amario. Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetimeESC Heart Failure 2022; 9(5): 3639 doi: 10.1002/ehf2.13963
2
R. Quinlivan, B. Messer, P. Murphy, R. Astin, R. Mukherjee, J. Khan, A. Emmanuel, S.C. Wong, R. Kulshresha, T. Willis, J. Pattni, D. Willis, A. Morgan, K. Savvatis, R. Keen, J. Bourke, C. Marini Bettolo, C. Hewamadduma. Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular DystrophyJournal of Neuromuscular Diseases 2021; 8(6): 899 doi: 10.3233/JND-200609
3
Metoprolol tartrate/sacubitril/valsartanReactions Weekly 2020; 1791(1): 173 doi: 10.1007/s40278-020-75018-9
4
John Bourke, Cathy Turner, William Bradlow, Ashish Chikermane, Caroline Coats, Matthew Fenton, Maria Ilina, Alexandra Johnson, Stam Kapetanakis, Lisa Kuhwald, Adrian Morley-Davies, Ros Quinlivan, Konstantinos Savvatis, Marianela Schiava, Zaheer Yousef, Michela Guglieri. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variationsOpen Heart 2022; 9(2): e001977 doi: 10.1136/openhrt-2022-001977
5
Pankaj Jariwala, Kartik Jadhav, Saket Khetan. Effectiveness and Safety of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction Secondary to Duchenne Muscular Dystrophy-Associated CardiomyopathyJournal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2023; 7(1): 31 doi: 10.4103/jiae.jiae_17_22
6
Yan Shen, Il-man Kim, Yaoliang Tang. Identification of Novel Gene Regulatory Networks for Dystrophin Protein in Vascular Smooth Muscle Cells by Single-Nuclear Transcriptome AnalysisCells 2023; 12(6): 892 doi: 10.3390/cells12060892
7
Samuel G. Wittekind, Chet R. Villa. Cardiac medication management in Duchenne muscular dystrophyPediatric Pulmonology 2021; 56(4): 747 doi: 10.1002/ppul.25175
8
Harshi Saxena, Neal L. Weintraub, Yaoliang Tang. Potential therapeutic targets for hypotension in duchenne muscular dystrophyMedical Hypotheses 2024; 185: 111318 doi: 10.1016/j.mehy.2024.111318
9
Saba Gharibi, Cyrille Vaillend, Angus Lindsay. The unconditioned fear response in vertebrates deficient in dystrophinProgress in Neurobiology 2024; 235: 102590 doi: 10.1016/j.pneurobio.2024.102590